BIOMAT Database Logo BIOMAT Database Logo

Fluphenazine decanoate: plasma concentrations and clinical response [proceedings]. 1978

H A Nasrallah, and L Rivera-Calimlin, and A D Rogol

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D005476 Fluphenazine A phenothiazine used in the treatment of PSYCHOSES. Its properties and uses are generally similar to those of CHLORPROMAZINE. Flufenazin,Fluphenazine Hydrochloride,Lyogen,Prolixin,Hydrochloride, Fluphenazine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder

Related Publications

H A Nasrallah, and L Rivera-Calimlin, and A D Rogol
Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response.
May 1991, The British journal of psychiatry : the journal of mental science,
H A Nasrallah, and L Rivera-Calimlin, and A D Rogol
Plasma imipramine concentrations in patients receiving concomitant fluphenazine decanoate.
January 1982, The American journal of psychiatry,
H A Nasrallah, and L Rivera-Calimlin, and A D Rogol
Plasma prolactin and fluphenazine concentrations in patients receiving fluphenazine decanoate: stability over injection intervals.
October 1987, International clinical psychopharmacology,
H A Nasrallah, and L Rivera-Calimlin, and A D Rogol
Fluphenazine plasma level monitoring for patients receiving fluphenazine decanoate.
January 2002, Schizophrenia research,
H A Nasrallah, and L Rivera-Calimlin, and A D Rogol
Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
February 1988, The Journal of clinical psychiatry,
H A Nasrallah, and L Rivera-Calimlin, and A D Rogol
Fluphenazine decanoate: a clinical problem?
January 1989, The American journal of psychiatry,
H A Nasrallah, and L Rivera-Calimlin, and A D Rogol
Plasma levels of fluphenazine during fluphenazine decanoate treatment in schizophrenia.
January 1985, Psychopharmacology,
H A Nasrallah, and L Rivera-Calimlin, and A D Rogol
Monitoring plasma levels of fluphenazine during chronic therapy with fluphenazine decanoate.
April 1995, Journal of clinical pharmacy and therapeutics,
H A Nasrallah, and L Rivera-Calimlin, and A D Rogol
Plasma fluphenazine levels in patients receiving two doses of fluphenazine decanoate.
January 1986, Psychopharmacology bulletin,
H A Nasrallah, and L Rivera-Calimlin, and A D Rogol
Fluphenazine plasma levels and clinical response.
January 1990, Psychopharmacology bulletin,
Copied contents to your clipboard!